Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
To invite people, share this page:
About This Webinar

ArcticZymes develops and manufactures novel, GMP-ready nucleases tailor made for bioprocessing applications. Using nucleases developed for optimal performance in your workflow helps you achieve purer product and higher titers, at a reduced cost. Our Salt Active Nuclease (SAN) is useful for removing residual DNA, particularily at the high-salt conditions often used in downstream processing of AAV vectors. M-SAN is a novel nuclease with excellent performance at physiological conditions found in typical cell media, in which nuclease treatment of more sensitive vectors is typically performed.

Language: English
Who can attend? Everyone
Featured Presenters
Webinar hosting presenter
Business Development Manager, North America
Jennifer is your local resource for ArcticZymes in the North America; she can help determine the best enzymatic solution for your particular application.
Webinar hosting presenter
Field Applications Manager
Jørn leads the technical support at ArcticZymes and will help adapting our enzymes to your workflows.
Webinar hosting presenter
Product Manager
Hans-Kristian is the product manager for the salt-active nuclease portfolio.
Webinar hosting presenter
Sr Business Development Manager Europe-North, Middle East and Asia
Kees is looking forward to discussing your needs in the host DNA depletion step of your DSP workflow.
Webinar hosting presenter
Business Development Manager Europe-South, South America and Africa
Laurent is looking forward to discussing your needs in the host DNA depletion step of your DSP workflow.
Webinar hosting presenter
Senior Market Development Manager Worldwide
You can reach out to Ineabel for general information on our products and inquiries about potential applications.
Hosted By
ASGCT 23rd Annual Meeting  webinar platform hosts ArcticZymes Salt-Active Nucleases
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents